Fluorescently Labeled Cetuximab-IRDye800 for Guided Surgical Excision of Ameloblastoma: A Proof of Principle Study is a research paper published in Journal of Oral and Maxillofacial Surgery (2020). On theSindex it has a DataRank of 0. It has been cited 13 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIDCR NIH HHS
Grant: L30 DE025411
NIDCR NIH HHS
Grant: K99 DE023826
NIDCR NIH HHS
Grant: R21 DE029603
NIDCR NIH HHS
Grant: R00 DE023826
National Institutes of Health
Oral and Maxillofacial Surgery Foundation
FWCI
1.40
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals